Jiali Xu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Circular RNAs in diseases 9
- Oncology 33
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Xuemei Jia (1 shared paper)Zhiqiang Yin (15 shared papers)Lingxiang Liu (9 shared papers)Yongmei Yin (11 shared papers)Wen Gao (4 shared papers)Yongqian Shu (7 shared papers)Weicheng Bei (9 shared papers)Dan Luo (6 shared papers)
- Journals
- PLoS ONE (4 papers)Frontiers in Cellular and Infection Microbiology (3 papers)Microbiology Spectrum (3 papers)Drug Design Development and Therapy (3 papers)Virulence (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jiali Xu
142 papers receiving 2.0k citations
Jiali Xu's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 556
- Oncology 413
- Molecular Biology 974
- Biological Psychiatry 34
- Immunology 284
Countries citing papers authored by Jiali Xu
This map shows the geographic impact of Jiali Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Xu more than expected).
Fields of papers citing papers by Jiali Xu
This network shows the impact of papers produced by Jiali Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Xu. The network helps show where Jiali Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiali Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 142 | |
| 2 | 2021 | 94 | |
| 3 | 2023 | 81 | |
| 4 | 2013 | 65 | |
| 5 | 2022 | 61 | |
| 6 | 2009 | 54 | |
| 7 | 2012 | 45 | |
| 8 | 2018 | 42 | |
| 9 | 2013 | 42 | |
| 10 | 2018 | 41 | |
| 11 | 2011 | 37 | |
| 12 | 2017 | 36 | |
| 13 | 2014 | 36 | |
| 14 | 2018 | 33 | |
| 15 | 2012 | 32 | |
| 16 | 2012 | 31 | |
| 17 | 2015 | 31 | |
| 18 | 2013 | 31 | |
| 19 | 2021 | 30 | |
| 20 | 2018 | 29 |
About Jiali Xu
Jiali Xu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 157 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (13 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Ferroptosis and cancer prognosis (10 papers), Circular RNAs in diseases (9 papers), Streptococcal Infections and Treatments (9 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Cancer Research (556 citations), Oncology (413 citations), Molecular Biology (974 citations), Biological Psychiatry (34 citations) and Immunology (284 citations). Jiali Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xuemei Jia, Zhiqiang Yin, Lingxiang Liu, Yongmei Yin, Wen Gao, Yongqian Shu, Weicheng Bei, Dan Luo, Huanchun Chen and Chengkun Zheng. Their work appears in journals such as PLoS ONE, Frontiers in Cellular and Infection Microbiology, Microbiology Spectrum, Drug Design Development and Therapy and Virulence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.